Congenital thrombophilia and thrombosis: a study in a single centre
Open Access
- 1 August 1999
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 81 (2), 176-178
- https://doi.org/10.1136/adc.81.2.176
Abstract
AIM To identify the incidence of congenital thrombophilia in a cohort of children presenting with symptomatic thromboembolism. METHOD A review of children with thromboembolism investigated for thrombophilia over a 12 month period. SUBJECTS Thirty children with thromboembolic episodes and 16 of their family members. MEASUREMENTS AND DATA COLLECTION Data were collected on age at diagnosis, underlying diagnosis, site of thrombosis, associated precipitating factors, occurrence of other thromboembolic events, and family history. Investigations included measurement of protein C activity, total and free protein S antigen, antithrombin III activity, screening for factor V Leiden and prothrombin 20210A, urinary homocysteine estimation, and a screen for lupus anticoagulant. RESULTS Twenty seven of 30 patients had one or more risk factors present at the time of thromboembolism. Eighty three per cent had acquired precipitating factors present, and 43% had underlying congenital thrombophilia. CONCLUSIONS There was a high incidence of congenital thrombophilia in this group of patients with symptomatic thromboembolism. These findings emphasise the importance of such defects in the pathogenesis of childhood thrombosis, and suggest that full thrombophilia investigations should be performed on all children presenting with thromboembolic disease.Keywords
This publication has 18 references indexed in Scilit:
- The A20210 Allele of the Prothrombin Gene Is Frequently Associated With the Factor V Arg 506 to Gln Mutation But Not With Protein S Deficiency in Thrombophilic FamiliesBlood, 1998
- Thrombosis in otherwise well children with the factor V Leiden mutationThe Journal of Pediatrics, 1996
- Factor V Leiden (FV R506Q) in Families with Inherited Antithrombin DeficiencyThrombosis and Haemostasis, 1996
- Childhood thrombosis.1995
- Incidence of activated protein C resistance caused by the ARG 506 GLN mutation in factor V in 113 unrelated symptomatic protein C-deficient patients. The French Network on the behalf of INSERMBlood, 1995
- Resistance to activated protein C as an additional genetic risk factor in hereditary deficiency of protein SBlood, 1995
- Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families.1994
- Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE.1994
- Venous thromboembolic complications in childrenThe Journal of Pediatrics, 1993
- Maturation of the hemostatic system during childhood.1992